467
Views
5
CrossRef citations to date
0
Altmetric
Clinical

Motor neuron disease beginning with frontotemporal dementia: clinical features and progression

ORCID Icon, , , , , , , , , & ORCID Icon show all
Pages 508-516 | Received 27 Jan 2021, Accepted 23 Mar 2021, Published online: 07 Jul 2021

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Inês Alves, Marta Gromicho, Miguel Oliveira Santos, Susana Pinto, Ana Pronto-Laborinho, Michael Swash & Mamede de Carvalho. (2023) Demographic changes in a large motor neuron disease cohort in Portugal: a 27 year experience. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 24:7-8, pages 614-624.
Read now

Articles from other publishers (4)

Ilaria Martinelli, Elisabetta Zucchi, Cecilia Simonini, Giulia Gianferrari, Giovanna Zamboni, Marcello Pinti & Jessica Mandrioli. (2023) The landscape of cognitive impairment in superoxide dismutase 1-amyotrophic lateral sclerosis. Neural Regeneration Research 18:7, pages 1427.
Crossref
Edoardo Nicolò Aiello, Sarah Feroldi, Giulia De Luca, Lucilla Guidotti, Eleonora Arrigoni, Ildebrando Appollonio, Federica Solca, Laura Carelli, Barbara Poletti, Federico Verde, Vincenzo Silani & Nicola Ticozzi. (2022) Primary progressive aphasia and motor neuron disease: A review. Frontiers in Aging Neuroscience 14.
Crossref
Mamede de Carvalho. (2022) Monitoring disease onset in amyotrophic lateral sclerosis. Nature Reviews Neurology 18:9, pages 513-514.
Crossref
David Reyes-Leiva, Oriol Dols-Icardo, Sonia Sirisi, Elena Cortés-Vicente, Janina Turon-Sans, Noemi de Luna, Rafael Blesa, Olivia Belbin, Victor Montal, Daniel Alcolea, Juan Fortea, Alberto Lleó, Ricard Rojas-García & Ignacio Illán-Gala. (2022) Pathophysiological Underpinnings of Extra-Motor Neurodegeneration in Amyotrophic Lateral Sclerosis: New Insights From Biomarker Studies. Frontiers in Neurology 12.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.